Literature DB >> 30651602

Negr1 controls adult hippocampal neurogenesis and affective behaviors.

Kyungchul Noh1, Hyunkyoung Lee1, Tae-Yong Choi1, Yeonhee Joo2, Soo-Joeng Kim1, Hyejin Kim2, Jin Young Kim3, Jeong Won Jahng3, Soojin Lee4, Se-Young Choi5, Sung Joong Lee6.   

Abstract

Recent genome-wide association studies on major depressive disorder have implicated neuronal growth regulator 1 (Negr1), a GPI-anchored cell adhesion molecule in the immunoglobulin LON family. Although Negr1 has been shown to regulate neurite outgrowth and synapse formation, the mechanism through which this protein affects mood disorders is still largely unknown. In this research, we characterized Negr1-deficient (negr1-/-) mice to elucidate the function of Negr1 in anxiety and depression. We found that anxiety- and depression-like behaviors increased in negr1-/- mice compared with wild-type mice. In addition, negr1-/- mice had decreased adult hippocampal neurogenesis compared to wild-type mice. Concurrently, both LTP and mEPSC in the dentate gyrus (DG) region were severely compromised in negr1-/- mice. In our effort to elucidate the underlying molecular mechanisms, we found that lipocalin-2 (Lcn2) expression was decreased in the hippocampus of negr1-/- mice compared to wild-type mice. Heterologous Lcn2 expression in the hippocampal DG of negr1-/- mice rescued anxiety- and depression-like behaviors and restored neurogenesis and mEPSC frequency to their normal levels in these mice. Furthermore, we discovered that Negr1 interacts with leukemia inhibitory factor receptor (LIFR) and modulates LIF-induced Lcn2 expression. Taken together, our data uncovered a novel mechanism of mood regulation by Negr1 involving an interaction between Negr1 and LIFR along with Lcn2 expression.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30651602     DOI: 10.1038/s41380-018-0347-3

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  3 in total

1.  Genetic deletion of Lsamp causes exaggerated behavioral activation in novel environments.

Authors:  Elizabeth Haldeman Catania; Aurea Pimenta; Pat Levitt
Journal:  Behav Brain Res       Date:  2007-12-07       Impact factor: 3.332

2.  NEGR1 and FGFR2 cooperatively regulate cortical development and core behaviours related to autism disorders in mice.

Authors:  Joanna Szczurkowska; Francesca Pischedda; Bruno Pinto; Francesca Managò; Carola A Haas; Maria Summa; Rosalia Bertorelli; Francesco Papaleo; Michael K Schäfer; Giovanni Piccoli; Laura Cancedda
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

3.  The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2.

Authors:  Francesca Pischedda; Giovanni Piccoli
Journal:  Front Mol Neurosci       Date:  2016-01-13       Impact factor: 5.639

  3 in total
  17 in total

1.  Placental NEGR1 DNA methylation is associated with BMI and neurodevelopment in preschool-age children.

Authors:  E Breton; V Gagné-Ouellet; K Thibeault; R Guérin; Rj Van Lieshout; P Perron; Mf Hivert; L Bouchard
Journal:  Epigenetics       Date:  2019-09-23       Impact factor: 4.528

2.  Receptor protein tyrosine phosphatase delta is not essential for synapse maintenance or transmission at hippocampal synapses.

Authors:  Kyung Ah Han; Hee-Yoon Lee; Dongseok Lim; Jungsu Shin; Taek Han Yoon; Xinran Liu; Ji Won Um; Se-Young Choi; Jaewon Ko
Journal:  Mol Brain       Date:  2020-06-17       Impact factor: 4.041

3.  Neural cell adhesion molecule Negr1 deficiency in mouse results in structural brain endophenotypes and behavioral deviations related to psychiatric disorders.

Authors:  Katyayani Singh; Mohan Jayaram; Maria Kaare; Este Leidmaa; Toomas Jagomäe; Indrek Heinla; Miriam A Hickey; Allen Kaasik; Michael K Schäfer; Jürgen Innos; Kersti Lilleväli; Mari-Anne Philips; Eero Vasar
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

Review 4.  Cell Adhesion Molecules and Protein Synthesis Regulation in Neurons.

Authors:  Irina Kozlova; Saroj Sah; Ryan Keable; Iryna Leshchyns'ka; Michael Janitz; Vladimir Sytnyk
Journal:  Front Mol Neurosci       Date:  2020-11-12       Impact factor: 5.639

5.  Lipocalin-2 Regulates Hippocampal Microglial Activation in Poststroke Depression.

Authors:  Li Wei; Yupeng Du; Yirui Xie; Xiaopeng Yu; Hui Chen; Yunqing Qiu
Journal:  Front Aging Neurosci       Date:  2021-12-13       Impact factor: 5.750

6.  Spatiotemporal expression of IgLON family members in the developing mouse nervous system.

Authors:  Sydney Fearnley; Reesha Raja; Jean-François Cloutier
Journal:  Sci Rep       Date:  2021-10-01       Impact factor: 4.379

Review 7.  Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics.

Authors:  Amanda M Buch; Conor Liston
Journal:  Neuropsychopharmacology       Date:  2020-08-11       Impact factor: 8.294

8.  Genome-wide association study of smoking trajectory and meta-analysis of smoking status in 842,000 individuals.

Authors:  Ke Xu; Boyang Li; Kathleen A McGinnis; Rachel Vickers-Smith; Cecilia Dao; Ning Sun; Rachel L Kember; Hang Zhou; William C Becker; Joel Gelernter; Henry R Kranzler; Hongyu Zhao; Amy C Justice
Journal:  Nat Commun       Date:  2020-10-20       Impact factor: 14.919

9.  Na/K-ATPase beta1-subunit associates with neuronal growth regulator 1 (NEGR1) to participate in intercellular interactions.

Authors:  Yeongmi Cheon; Ara Yoo; Hyunseok Seo; Seo-Young Yun; Hyeonhee Lee; Heeji Lim; Youngho Kim; Lihua Che; Soojin Lee
Journal:  BMB Rep       Date:  2021-03       Impact factor: 4.778

10.  Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions.

Authors:  Daniel F Levey; Murray B Stein; Frank R Wendt; Gita A Pathak; Hang Zhou; Mihaela Aslan; Rachel Quaden; Kelly M Harrington; Yaira Z Nuñez; Cassie Overstreet; Krishnan Radhakrishnan; Gerard Sanacora; Andrew M McIntosh; Jingchunzi Shi; Suyash S Shringarpure; John Concato; Renato Polimanti; Joel Gelernter
Journal:  Nat Neurosci       Date:  2021-05-27       Impact factor: 28.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.